HOME >> BIOLOGY >> NEWS
Thyroid treatment can trigger homeland security detectors

CHICAGO Medical procedures such as iodine therapy, a popular thyroid treatment, can result in patients triggering radiation detectors for up to three months after treatment, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Diagnostic nuclear medicine procedures, including FDG PET scans, bone scans and cardiac scans, can have a similar effect, although for shorter periods.

"The nuclear medicine community has been aware that patients set off detectors, but now we expect it to become a more common occurrence with the increasing number of extremely sensitive portable Homeland Security radiation detectors deployed among security personnel," said the study's author, Lionel Zuckier, M.D., a radiology professor at the New Jersey Medical School - University of Medicine and Dentistry of New Jersey and director of nuclear medicine and PET at University Hospital in Newark, New Jersey. "Our study helps estimate the amount of time following a procedure that these detectors can still be triggered."

The amount of radiation a patient receives in a typical nuclear medicine imaging procedure is comparable to that received from an x-ray and poses no danger to the public.

Radiopharmaceuticals are radioactively labeled drugs that interact with specific organs or tissues and can be imaged using specialized cameras and computers. In therapeutic procedures, greater amounts of radioactivity are directed to specific tissues, and patients may be sequestered from the public for several days.

In their study, Dr. Zuckier and colleagues estimated the maximum length of time that diagnostic and therapeutic radiopharmaceuticals could set off radiation detectors such as those used for Homeland Security purposes, specifically:

  • FDG PET scan less than 24 hours
  • Bone and thyroid scans 3 days
  • Cardiac exams with thallium up to 30 days
  • Iodine t
    '"/>


  • Contact: Doug Dusik
    ddusik@rsna.org
    630-590-7762
    Radiological Society of North America
    30-Nov-2004


    Page: 1 2

    Related biology news :

    1. Thyroid cancer discovery points to new treatments, prevention
    2. Thyroid hormone, brain development, and behavior
    3. New system of wastewater treatment could reduce the size of treatment plants by half
    4. UCF research links proteins, stem cells and potential Alzheimers treatment
    5. Geisinger scientist seeks cure for Lou Gehrigs disease, creating device to find treatment
    6. System to analyze beating heart stem cells could lead to heart attack treatments
    7. Gene expression pattern could lead to improved treatment of pediatric septic shock
    8. Molecular detectors may refine cancer treatment
    9. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
    10. A new method of adult stem cell growth efficacious in treatment of disorders of the cornea
    11. Scientists take next step in understanding potential target for ovarian cancer treatment

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    TAG: Thyroid treatment can trigger homeland security detectors

    (Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
    (Date:4/21/2015)... 21, 2015 High crime ... are boosting access control systems market in ... a recently published report by TechSci Research " Saudi ... access control systems market in Saudi Arabia ... 2020.The access control systems market in the Kingdom is ...
    (Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
    Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
    (Date:5/22/2015)... 2015 Knowledgent , the data ... explores the potential of big data analytics in the ... developed to help life sciences and healthcare organizations understand ... gain critical business insights. , The life sciences and ... driven by patient profiling, compliance and regulatory requirements, and ...
    (Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
    (Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
    (Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
    Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
    Cached News: